FDA 483 - AG Essence, Inc. - February 26, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
AG Essence, Inc. in Sandston, VA, a contract manufacturer of OTC animal drug products, was cited for significant deficiencies in its quality control and manufacturing processes. The inspection revealed failures in process validation, equipment cleaning procedures, raw material identity testing, and microbiological testing for product release. These issues collectively indicate a systemic breakdown in GMP compliance for their animal drug products, raising concerns about product quality and safety.
ID · ffb1d3c9-56de-497b-bd20-df38bdf0780d